Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

NCT00501293 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
163
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Noven Therapeutics